MKK4 inhibitor: the hope for liver failure prevention and potential small liver graft transplantation

Keywords

Liver regeneration / Partial hepatectomy / MKK4 / Drug discovery and development / First-in-human phase I trial

References

[1] Wuestefeld T, Pesic M, Rudalska R, et al. A direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration[J]. Cell, 2013, 153(2): 389-401.

[2] Lin A, Minden A, Martinetto H, et al. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2[J]. Science, 1995, 268(5208): 286-290.

[3] Hanks SK, Quinn AM, Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains[J]. Science, 1988, 241(4861): 42-52.

[4] Yan M, Dai T, Deak JC, et al. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1[J]. Nature, 1994, 372(6508): 798-800.

[5] Deacon K, Blank JL. Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3[J]. J Biol Chem, 1997, 272(22): 14489-14496.

[6] Shevchenko E, Poso A, Pantsar T. The autoinhibited state of MKK4: phosphorylation, putative dimerization and R134W mutant studied by molecular dynamics simulations[J]. Comput Struct Biotechnol J, 2020, 18: 2687-2698.

[7] Jiang J, Jiang B, He Z, et al. Discovery of covalent MKK4/7 dual inhibitor[J]. Cell Chem Biol, 2020, 27(12): 1553-1560.

[8] Lee DE, Lee KW, Byun S, et al. 7,3′4′-Trihydroxyisoflavone, a metabolite of the soy isoflavone daidzein, suppresses ultraviolet B-induced skin cancer by targeting Cot and MKK4[J]. J Biol Chem, 2011, 286(16): 14246-14256.

[9] Lee JH, Kim JE, Jang YJ, et al. Dehydroglyasperin C suppresses TPA-induced cell transformation through direct inhibition of MKK4 and PI3K[J]. Mol Carcinog, 2016, 55(5): 552-562.

[10] Xu L, Ding Y, Catalona WJ, et al. MEK4 function, genistein treatment, and invasion of human prostate cancer cells[J]. J Natl Cancer Inst, 2009, 101(16): 1141-1155.

[11] Zwirner S, Abu Rmilah AA, Klotz S, et al. First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure[J]. Cell, 2024, 187(7): 1666-1684.

Funding

National Natural Science Foundation of China(82074068)

National Natural Science Foundation of China(82373912)

National Natural Science Foundation of China(82300685)

National Key R&D Program of China(2023YFD1601400)

Fundamental Research Funds for the Central Universities(2632022YC04)

Jiangsu Outstanding Youth Fund Project(BK20231535)

Natural Science Foundation of Jiangsu Province(BK20221052)

Jiangsu Funding Program for Excellent Postdoctoral Talent(2022ZB286)